Multiple sclerosis patients talk medical marijuana

More and more evidence is accumulating that denying medical cannabis to patients suffering from diseases likes multiple sclerosis should no longer be acceptable under any state’s law.

Laboratory, pre-clinical and clinical trials have all backed up the use of medical cannabis products for the disease, and patients back up what the science is saying.

Patients have a right to safe, life-saving botanicals and they’re not waiting around for the federal government or recalcitrant states. They’re getting recommendations for cannabis in one of 23 medical marijuana states, and seeking out formulations like mouth sprays and CBD-rich edibles that specifically help with M.S. symptoms.

Over 400,000 people in the United States and about 2.5 million people around the world have Multiple Sclerosis (MS). About200 new cases are diagnosed each week in the United States alone. While most people are diagnosed between the ages of 20-40, MS...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.